Novel nanosensors for rapid analysis of telomerase activity

被引:112
作者
Grimm, J [1 ]
Perez, JM [1 ]
Josephson, L [1 ]
Weissleder, R [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Boston, MA USA
关键词
D O I
10.1158/0008-5472.CAN-03-2798
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Elevated telomerase levels are found in many malignancies, offering an attractive target for therapeutic intervention and diagnostic or prognostic purposes. Here we describe the use of a novel nanosensor developed for rapid screens of telomerase activity in biological samples. The technique utilizes magnetic nanoparticles that, on annealing with telomerase synthesized TTAGGG repeats, switch their magnet state, a phenomenon readily detectable by magnetic readers. We tested the efficacy of different telomerase inhibitors in crude human and murine samples and show that phosphorylation of telomerase regulates its activity. High-throughput adaptation of the technique by magnetic resonance imaging allowed processing of hundreds of samples within tens of minutes at ultrahigh sensitivities. Together, these studies establish and validate a novel and powerful tool for rapidly sensing telomerase activity and provide the rationale for developing analogous magnetic nanoparticles for in vivo sensing.
引用
收藏
页码:639 / 643
页数:5
相关论文
共 56 条
[1]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[2]   A critical role for telomeres in suppressing and facilitating carcinogenesis [J].
Artandi, SE ;
DePinho, RA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :39-46
[3]  
Avilion AA, 1996, CANCER RES, V56, P645
[4]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[5]  
CASTAGNA M, 1982, J BIOL CHEM, V257, P7847
[6]   Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression [J].
Chang, S ;
Khoo, CM ;
Naylor, ML ;
Maser, RS ;
DePinho, RA .
GENES & DEVELOPMENT, 2003, 17 (01) :88-100
[7]   Telomerase inhibitors: A new option for chemotherapy [J].
Chen, Z ;
Corey, DR .
ADVANCES IN CANCER RESEARCH, VOL 87, 2003, 87 :31-58
[8]   Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: Application to colorectal cancers [J].
Cheng, AJ ;
Tang, RP ;
Wang, JY ;
Chang, JT ;
Wang, TCV .
JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (03) :280-285
[9]   Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase [J].
Counter, CM ;
Meyerson, M ;
Eaton, EN ;
Ellisen, LW ;
Caddle, SD ;
Haber, DA ;
Weinberg, RA .
ONCOGENE, 1998, 16 (09) :1217-1222
[10]   A highly selective telomerase inhibitor limiting human cancer cell proliferation [J].
Damm, K ;
Hemmann, U ;
Garin-Chesa, P ;
Hauel, N ;
Kauffmann, I ;
Priepke, H ;
Niestroj, C ;
Daiber, C ;
Enenkel, B ;
Guilliard, B ;
Lauritsch, I ;
Müller, E ;
Pascolo, E ;
Sauter, G ;
Pantic, M ;
Martens, UM ;
Wenz, C ;
Lingner, J ;
Kraut, N ;
Rettig, WJ ;
Schnapp, A .
EMBO JOURNAL, 2001, 20 (24) :6958-6968